' Like a Coin Flip ' : Assay Denies Some Cancer Patients New Drug ' Like a Coin Flip ' : Assay Denies Some Cancer Patients New Drug

The test that determines the eligibility of breast cancer patients to receive atezolizumab is like flipping a coin in terms of accuracy, says a critic. The manufacturer, Roche, says it is effective.Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news